GeneNews appoints Patrick Terry
GeneNews appointed Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM)the company's blood test for colorectal cancer. Don't know much about GEN.TO except it's got some top flight people on its medical advisor board. P. Terry is a winner everywhere he goes. Got to find a Canadian broker who knows GeneNews.